Anemia Treatment Drugs Market 2018-2026 | Size, Share and Forecast | Credence Research
Mar 18, 2019
The Anemia Treatment Drugs market was estimated at USD 23,155.8 million in 2017 and is expected to grow at a CAGR of 16.4 percent during the forecast period 2018 to 2026.
SANJOSE, United States - March 18, 2019 /MarketersMedia/ —
According to the latest report published by Credence Research, Inc. "Anemia Treatment Drugs Market - Growth, Future Prospects and Competitive Analysis, 2018 - 2026," the Anemia Treatment Drugs market was valued at USD 23,155.8 million in 2017 and is expected to grow at a CAGR of 16.4 percent during the forecast period 2018 to 2026.
Market Insight:
Anemia is the most common hematological disorder and affects more than 3 million Americans each year, according to the American Society of Hematology. The global scenario is more worrying because the World Health Organization states that anemia affects around 1.62 billion people worldwide, which is equal to 22.5 percent of the global population. In addition to the highest prevalence of anemia was found in pre-school-age children and the lowest prevalence is in men. In addition, the highest number of individuals affected by anemia after pre-school-age children are non-pregnant women, about 31.2 percent of the total anemic population. The treatment specifically depends on the type of anemia and other complications associated with it. Currently, the treatment for anemia specifically focuses on supplements and chronic conditions are directly treated with blood transfusion, stem cell transplant or bone marrow transplant.
Browse the full report Anemia Treatment Drugs Market - Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/anemia-treatment-drugs-market
The major types of anemia treated with drugs are Iron Deficiency Anemia, Thalassemia, Aplastic anemia, Hemolytic anemia, sickle cell anemia, and pernicious anemia. In 2017, iron deficiency anemia and sickle cell anemia together dominated the market, accounting for nearly 60 percent of market share. The key factors responsible for the growth of these two types of anemia are sickle cell anemia and aplastic anemia has the highest prevalence, and the available drug treatment costs more compared to other types. These two types of anemia are expected to maintain their dominance throughout the forecast period due to expected market entry of more than 10 molecules during the forecast period from 2018 to 2026.
The anemia treatment drugs market comprises drugs such as vitamins & iron supplements, antibiotics, immunosuppressant, bone marrow stimulants, corticosteroids, gene therapy & iron chelating agents. In 2017, immunosuppressant & corticosteroids accounted for a combined market share of 58% due to key market driving factors such as rising prevalence of anemia, increasing awareness related to anemia with the initiative of government & non-government organizations, and incessant advancement in the research & development of anemia treatment industry. The drug pipeline of anemia treatment is very strong and several prominent players are present along with their promising molecules. The most efficient molecules present in the drug pipeline are FG-4592/roxadustat (FibroGen), Daprodustat/GSK1278863 (GlaxoSmithKline), Molidustat/BAY85-3934 (Bayer), Rivipansel (Pfizer), Luspatercept (Celgene), OMS721 (Omeros Corporation), and LentiGlobin BB305 (bluebird bio). Thus, such as strong drug pipeline is expected to drive the overall anemia treatment drugs market significantly throughout the forecast period.
Market Competition Assessment:
The anemia treatment drugs market is expected to grow significantly in the near future and there are several companies operating in this market and expected to enter the market. The overall competitive scenario is expected to observe a paradigm shift towards gene therapy & monoclonal antibody therapies. The key players present in this market are Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals, GlaxoSmithKline plc, Akebia Therapeutics, Vifor Pharma Management, Ltd., and FibroGen, Inc. among others.
Key Market Movements:
Increasing prevalence of anemia and its types in developed as well as developing countries
Rising awareness in developing countries due to initiative and programs introduced by government and non-government organizations
Incessant development in the field of research and development in anemia treatment
The major competition for the available drugs is from stem cell transplantation and upcoming pipeline drugs in the near future
Get Sample (Free) @ https://www.credenceresearch.com/sample-request/59597
Follow us on social media to get new updates as soon as they are available as well as hear about unique business opportunities
Linkedin
Twitter
ToC:
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Global Anemia Treatment Drugs Market: Market Dynamics and Future Outlook
Chapter 4. Global Anemia Treatment Drugs Market, by Type of Anemia, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Iron deficiency anemia
4.3. Thalassemia
4.4. Aplastic anemia
4.5. Hemolytic anemia
4.6. Sickle cell anemia
4.7. Pernicious anemia
Chapter 5. Global Anemia Treatment Drugs Market, by Type of Drug, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Supplements
5.3. Antibiotics
5.4. Immunosuppresants
5.5. Bone Marrow Stimulants
5.6. Corticosteroids
5.7. Gene Therapy
5.8. Iron Chelating Agents
5.9. Pipeline Analysis: Global Anemia Treatment Drugs Market
5.9.1. Overview
5.9.2. Phase III Drugs: Market Size Forecast till 2026 (US$ Mn)
5.9.2.1. FG-4592/Roxadustat (FibroGen)
5.9.2.2. Daprodustat/GSK1278863 (GlaxoSmithKline)
5.9.2.3. Molidustat/BAY85-3934 (Bayer)
5.9.2.4. MT-6548 (Mitsubishi Tanabe Pharma Corporation)
5.9.2.5. Rivipansel/GMI-1070 (Pfizer)
5.9.2.6. Luspatercept (Celgene)
5.9.2.7. AG-348 (Agios Pharmaceuticals, Inc.)
5.9.2.8. Sutimlimab (Bioverativ Therapeutics Inc.)
5.9.2.9. V114 (Merck Sharp & Dohme Corp.)
5.9.2.10. LentiGlobin/BB305 (bluebird bio)
5.9.2.11. APL-2 (Apellis Pharmaceuticals, Inc.)
5.9.2.12. ALXN1210 (Alexion Pharmaceuticals)
5.9.2.13. OMS721 (Omeros Corporation)
5.9.3. Phase II (Tabular Representation)
5.9.4. Phase I (Tabular Representation)
................
......................
Chapter 7. Company Profiles
7.1. Amgen, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Hoffmann-La Roche Ltd.
7.3. Novartis AG
7.4. Pfizer, Inc.
7.5. Janssen Pharmaceuticals, Inc.
7.6. Teva Pharmaceutical Industries, Ltd.
7.7. AMAG Pharmaceuticals
7.8. Rockwell Medical
7.9. Akebia Therapeutics
7.10. Vifor Pharma Management, Ltd.
7.11. FibroGen, Inc.
7.12. GlaxoSmithKline plc
7.13. Bayer AG
7.14. Omeros Corporation
7.15. Merck Sharp & Dohme Corp.
................................toc continued
Browse the full report Anemia Treatment Drugs Market - Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/anemia-treatment-drugs-market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com
Source: MarketersMedia
Release ID: 493187
‘High hopes’ as Indonesia’s women get another shot at national football league
Seven years after Covid-19 put the brakes on Indonesia’s new women’s football league, Zahra Naqiyyah will finally return to the field with “high hopes” for the women’s game in the country. Sunday’s matches in the Indonesia Women’s League will be the first since 2019 and a new chapter for women’s football in the Muslim-majority country of 290 million people. “I really believe that if Indonesia’s women’s football is properly managed, we can become a powerhouse in Asia,” Zahra said at a training...
Frankie Lor sets Stormy Grove on path to Hong Kong Mile with Group Two Sha Tin Trophy test
Frankie Lor Fu-chuen is hoping last season’s Classic Cup winner Stormy Grove can pass his first test on the road to the Group One Hong Kong Mile when he tackles Monday’s Group Two Sha Tin Trophy (1,600m). The Toronado galloper soared from the back of the field to collect the second leg of last season’s Classic Series, before running a mighty race to finish third in the Hong Kong Derby (2,000m) behind Invincible Ibis. His season ended prematurely on his next start, however, as he bled from both...
Promising Chinese teen basketball player joins top US high school, sparking training debate
A top American high school snapping up a talented Chinese teen basketball player once deemed “too short” to represent the national team has sparked debate online about the country’s rigid training and selection criteria. Zhang Yuchen, who has drawn similarities to Golden State Warriors star Stephen Curry, left Guangzhou for Phoenix on Wednesday to join the CIA Bella Vista’s men’s basketball team. Winning both the Chipotle High School Basketball Nationals and the EYBL Scholastic titles last...
Sydney’s wet weather has Zac Purton more hopeful than confident in Ka Ying Rising
Persistent rain in Sydney has Zac Purton more hopeful than confident in Ka Ying Rising as the champion sprinter bids to defend his crown in the Group One The Everest (1,200m) at Randwick on Saturday. Purton is concerned about Ka Ying Rising’s ability to handle a wet track, with Randwick rated a heavy 8 on Thursday after heavy rain earlier in the week and more showers on Thursday. The world’s best racehorse has only raced on an official rain-affected track once in Hong Kong, winning the 2024...
Asian Cup could be switched to 2028, tennis’ Six Kings Slam delayed over Saudi bomb fears
The Six Kings Slam tennis tournament originally scheduled for October has been pushed back to late December, Fifa’s esports finals have been postponed, and officials are considering whether to move the Asian Cup to 2028, after the recent attacks on Saudi Arabia. A strike on Riyadh’s international airport on Saturday killed at least 12 people and wounded more than 300, with Yemen’s Iran-aligned Houthi movement claiming responsibility for the deadliest attack in the kingdom in more than a...
ACL 2: Tai Po braced to face ex-England junior player on roll as coach in Far East
Mark Jackson was a good enough footballer to make 18 Premier League appearances for Leeds United; to play at Old Trafford, Goodison Park, Highbury and Anfield; and to keep the prolific Ian Wright off the scoresheet in an FA Cup victory over Arsenal. As a coach, he led Leeds’ under-18 and under-23 teams to league titles. None of that afforded Jackson a second crack at management in his native England, after his first chance with MK Dons lasted only 4½ months. Not for Jackson the mulligan that is...
Derby winner Massive Sovereign rolls back the years in dominant Happy Valley success
Former Hong Kong Derby winner Massive Sovereign rolled back the years with a devastating turn of foot to win at Happy Valley on Wednesday night and has Frankie Lor Fu-chuen dreaming of Group One targets. A dual winner in Ireland pre-import, the No Nay Never galloper was a revelation in his opening local starts, using a Class Three success as a stepping stone to Derby glory when trained by Dennis Yip Chor-hong in 2024. Injuries have plagued the six-year-old since, however, and he had only run...
Regulator expects Man City to face January showdown over breaches of Premier League rules
The chair of English football’s independent regulator has said he expects Manchester City’s appeal after being found guilty of more than 100 breaches of Premier League financial rules to be heard by January. City, who have repeatedly maintained they are innocent of the charges, are currently top of the Premier League table with six wins out of six following their 3-0 win over Liverpool last weekend. No sanction has yet been announced, but City could face a heavy points deduction leading to...
Culprits found, say sorry after sparking flashpoint during WTT China Smash final
A table tennis team from Chinese Taipei have issued a formal apology on Wednesday after video footage confirmed two of their junior players accidentally triggered a camera flash that disrupted the men’s singles final at the WTT China Smash in Beijing. The incident had initially drawn heavy scrutiny on Japan’s newly crowned world No 1 Sora Matsushima, who was penalised with a yellow card for abruptly interrupting play to complain about the flash and subsequently accused by fans of using...
A place in university the next goal for Chinese athlete Chen Yujie, Asia’s fastest woman
Fresh from a dominant showing at the Asian Games, teenage track star Chen Yujie is balancing professional training for next year’s world championships with preparations for the national college entrance examinations, setting her sights on a local university. At the recently concluded 20th Asian Games in Aichi-Nagoya, the 17-year-old bagged four medals before returning home to resume life in the final year of high school. Chen won gold medals in the 100m and two relays, and a silver in the...
Chris Waller admits ‘it looks a tough ask’ to beat champion Ka Ying Rising in The Everest
Chris Waller concedes “it looks a tough ask” to beat Ka Ying Rising as Sydney’s leading trainer bids to dethrone the Hong Kong champion with a dual-pronged assault on Saturday’s Group One The Everest (1,200m) at Randwick. New Zealand-born Waller will saddle top sprinter Joliestar and Angel Capital in the A$20 million (HK$109.87 million) feature, but he rates Ka Ying Rising as clearly the horse to beat despite the prospect of an unsuitable wet track. A sensational winner of 21 consecutive races,...
South Korean FA condemns ‘personal attacks, criticism’ of players as attempt to sow discord
South Korea’s football association has told fans to stop “excessive personal attacks”, warning of the “psychological burden” they could inflict on national team players in the crosshairs since their World Cup flop. Hong Myung-bo quit as coach after the team failed to advance past the group stage in North America, and Spanish interim manager Robert Moreno is awaiting word on a possible extension. With the Asian Cup scheduled to take place in January in Saudi Arabia, the national side are engulfed...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.